Prospects of immune gene therapy for cancer

Prospects of immune gene therapy for cancer

Dades bibliogràfiques
Autors principals:	Hardwick, N, Chan, L, Darling, D, Gaken, J, Galea-Lauri, J
Format:	Journal article
Publicat:	2004

Ítems similars

An immune edited tumour versus a tumour edited immune system: Prospects for immune therapy of acute myeloid leukaemia.
per: Chan, L, et al.
Publicat: (2006)

Novel costimulators in the immune gene therapy of cancer.
per: Galea-Lauri, J, et al.
Publicat: (1996)

A polycistronic retroviral vector encoding hB7-1 (CD80) and hIL-2 for ex vivo cancer gene therapy.
per: Kuiper, M, et al.
Publicat: (1996)

High titre vectors for targeted expression of multiple genes
per: Darling, D, et al.
Publicat: (2004)

Monocistronic high titre vectors for targeted expression of multiple therapeutic genes
per: Darling, D, et al.
Publicat: (2004)

IL-2/B7.1 fusagene transduction of AML blasts by a self-inactivating lentiviral vector stimulates T cell responses in vitro: A strategy to generate whole cell vaccines for AML
per: Chan, L, et al.
Publicat: (2004)

IL-2/B7.1 (CD80) fusagene transduction of AML blasts by a self-inactivating lentiviral vector stimulates T cell responses in vitro: a strategy to generate whole cell vaccines for AML.
per: Chan, L, et al.
Publicat: (2005)

Tumour cells expressing B7.1 costimulatory molecule: Are these better targets for NK cells?
per: GaleaLauri, J, et al.
Publicat: (1996)

In vitro immune modulation by antibodies coupled to tumour cells.
per: Darling, D, et al.
Publicat: (1997)

Low-speed centrifugation of retroviral vectors absorbed to a particulate substrate: a highly effective means of enhancing retroviral titre.
per: Darling, D, et al.
Publicat: (2000)

Expression of a variant of CD28 on a subpopulation of human NK cells: implications for B7-mediated stimulation of NK cells.
per: Galea-Lauri, J, et al.
Publicat: (1999)

Conjugation of lentivirus to paramagnetic particles via nonviral proteins allows efficient concentration and infection of primary acute myeloid leukemia cells.
per: Chan, L, et al.
Publicat: (2005)

Fusagene vectors: A novel strategy for the expression of multiple genes from a single cistron
per: Gaken, J, et al.
Publicat: (1998)

Induction of tumour rejection by autologous and allogeneic tumour cells expressing B7.1 and IL-2.
per: Hirst, W, et al.
Publicat: (1996)

Fusagene vectors: a novel strategy for the expression of multiple genes from a single cistron.
per: Gäken, J, et al.
Publicat: (2000)

Fusagene vectors: a novel strategy for the expression of multiple genes from a single cistron
per: Gaken, J, et al.
Publicat: (2001)

A comparison of CTL induction by different methods of antigen loading of monocyte-derived dendritic cells
per: Galea-Lauri, J, et al.
Publicat: (2001)

Induction of tumour rejection by B7.1 and IL-2 expressing tumour cells
per: Gaken, J, et al.
Publicat: (1997)

Strategies for antigen choice and priming of dendritic cells influence the polarization and efficacy of antitumor T-cell responses in dendritic cell-based cancer vaccination.
per: Galea-Lauri, J, et al.
Publicat: (2004)

Influence of interleukin-4 on the phenotype and function of bone marrow-derived murine dendritic cells generated under serum-free conditions.
per: Wells, J, et al.
Publicat: (2005)

Streptavidin paramagnetic particles provide a choice of three affinity-based capture and magnetic concentration strategies for retroviral vectors.
per: Hughes, C, et al.
Publicat: (2001)

Dendritic cell/tumour fusions are more efficient at eliciting MHC class I-restricted Ag-specific CTL responses when compared to antigen-pulsed dendritic cells
per: Galea-Lauri, J, et al.
Publicat: (2001)

Affinity mediated magnetic concentration of retroviral vectors
per: Hughes, C, et al.
Publicat: (2001)

Retroviral vectors for use in human gene therapy for cancer, Gaucher disease, and arthritis.
per: Robbins, P, et al.
Publicat: (1994)

Efficient retroviral infection of mammalian cells is blocked by inhibition of poly(ADP-ribose) polymerase activity.
per: Gäken, J, et al.
Publicat: (1996)

Eliciting cytotoxic T lymphocytes against acute myeloid leukemia-derived antigens: evaluation of dendritic cell-leukemia cell hybrids and other antigen-loading strategies for dendritic cell-based vaccination.
per: Galea-Lauri, J, et al.
Publicat: (2002)

Irradiated NC adenocarcinoma cells transduced with both B7.1 and interleukin-2 induce CD4+-mediated rejection of established tumors.
per: Gaken, J, et al.
Publicat: (1997)

Cloning and Characterization of a Retroviral Plasmid, pCC1, for Combination Suicide Gene Therapy
per: Marcel Kuiper, et al.
Publicat: (2000-03-01)

Gene Transfer for Immune Therapy of Cancer
per: Claudio Bordignon
Publicat: (1999-06-01)

The Progress and Prospects of Immune Cell Therapy for the Treatment of Cancer
per: Jia Han, et al.
Publicat: (2024-03-01)

Gene therapy in the treatment of cancer : progress and prospects /
per: Huber, Brian E., et al.
Publicat: (1998)

Immunological weapons against acute myeloid leukaemia.
per: Galea-Lauri, J
Publicat: (2002)

Semi-allogeneic dendritic cells can induce antigen-specific T-cell activation, which is not enhanced by concurrent alloreactivity.
per: Wells, J, et al.
Publicat: (2007)

Current Status and Prospect of Lung Cancer Gene Therapy
per: Lingling ZU, et al.
Publicat: (2011-09-01)

Prospects of systemic enzyme therapy for treatment of male immune infertility
per: S. N. Kalininа, et al.
Publicat: (2020-04-01)

Innate immune immunity and viral therapy of cancer
per: Glen N. Barber

Cancer gene therapy: Prospects of using human sodium iodide symporter gene in non-thyroidal cancer
per: Shruti Dutta, et al.
Publicat: (2015-01-01)

Emerging Roles for Eph Receptors and Ephrin Ligands in Immunity
per: Thayer K. Darling, et al.
Publicat: (2019-07-01)

Editorial: Gene Therapy in the CNS – Progress and Prospects for Novel Therapies
per: Marco Ledri, et al.
Publicat: (2021-10-01)

The role of the 90-kDa heat shock protein in cell cycle control and differentiation of the monoblastoid cell line U937.
per: Galea-Lauri, J, et al.
Publicat: (1996)